Cargando…
Soluble guanylyl cyclase as a therapeutic target in chronic obstructive pulmonary disease (COPD)
Autores principales: | Glynos, Constantinos, Toumpanakis, Dimitris, Zhou, Zongmin, Brouckaert, Peter, Vassilakopoulos, Theodoros, Papapetropoulos, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765548/ http://dx.doi.org/10.1186/2050-6511-14-S1-P25 |
Ejemplares similares
-
Regulation of soluble guanylyl cyclase by phosphorylation
por: Zhou, Zongmin, et al.
Publicado: (2009) -
Regulation of soluble guanylyl cyclase by phosphorylation
por: Zhou, Zongmin, et al.
Publicado: (2009) -
Nucleotidyl cyclase activity of recombinant soluble guanylyl cyclase
por: Rauch, Kerstin, et al.
Publicado: (2009) -
NO resistance in angiotensin II–induced hypertension is associated with S-nitrosation of soluble guanylyl cyclase
por: Crassous, Pierre-Antoine, et al.
Publicado: (2011) -
Study on the involvement of soluble guanylyl cyclase and its different isoforms in carbon monoxide and carbon monoxide releasing molecule-2 induced vasodilatation
por: Decaluwé, Kelly, et al.
Publicado: (2011)